3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Sensor-Based Optimization of Therapy for Parkinson's Disease Patients With Motor FluctuationsDyskinesias, Hypokinesia, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathyNot yet recruitingNot applicable2026-09-02NCT07074119
Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's DiseaseDisruptive, Impulse Control, and Conduct Disorders, Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, impulse control disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathyNot yet recruitingNot applicable2026-06-12NCT07505394
Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.Disruptive, Impulse Control, and Conduct Disorders, Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathyNot yet recruitingNot stated2025-01-01NCT06754553